Floatz logo

Iodixanol

Glioblastoma

Centre Hospitalier Universitaire de NīmesSmall moleculeN/ADormant
D
28/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
65/ 100

Competitive context

234 Active assets in the Glioblastoma cohort.

Asset / SponsorPhaseRating
(+)-VINCRISTINE
University of Cincinnati
Phase 3BB
Enzastaurin
Denovo Biopharma LLC
Phase 3BB
Inno-206
Université de Sherbrooke
Phase 2BB
ETOPOSIDE
Sichuan Honghe Biotechnology Co., Ltd.
Phase 2/3BB
Paxalisib
Institute of Cancer Research, United Kingdom
Phase 2/3B

View all 50 →

Same molecule, other indications

Iodixanol is also rated in:

carotid stenosisDormant
B
Indicative ·
63 / 100
View asset →
atherosclerosisDormant
B
Indicative ·
62 / 100
View asset →
Colon CancerDormant
B
Indicative ·
59 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →